 Clinical use ganciclovir cytomegalovirus infection development drug resistance Cytomegalovirus CMV infection common patients advanced human immunodeficiency virus infection variety clinical syndromes Ganciclovir guanosine analogue CMV DNA polymerase active form patients CMV retinitis induction therapy ganciclovir results high rates clinical virologic response maintenance therapy progression disease Clinically relevant resistance CMV phosphorylation ganciclovir active form cells resistant strains CMV ganciclovir-phosphorylating enzyme function mutation resistance Further study mechanism resistance prevalence resistance clinical setting